FALSE0001121404--12-316/30/20242024Q2iso4217:EURxbrli:sharesiso4217:EURxbrli:sharesxbrli:pureiso4217:USDiso4217:USDxbrli:sharessny:proceedingsny:segment00011214042024-01-012024-06-3000011214042024-06-3000011214042023-12-3100011214042023-01-012023-06-3000011214042023-01-012023-12-310001121404ifrs-full:IssuedCapitalMember2022-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2022-12-310001121404ifrs-full:TreasurySharesMember2022-12-310001121404ifrs-full:RetainedEarningsMember2022-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2022-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2022-12-310001121404ifrs-full:NoncontrollingInterestsMember2022-12-3100011214042022-12-310001121404ifrs-full:RetainedEarningsMember2023-01-012023-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-01-012023-06-300001121404ifrs-full:NoncontrollingInterestsMember2023-01-012023-06-300001121404ifrs-full:TreasurySharesMember2023-01-012023-06-300001121404ifrs-full:IssuedCapitalMember2023-01-012023-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2023-01-012023-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-01-012023-06-300001121404ifrs-full:IssuedCapitalMember2023-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2023-06-300001121404ifrs-full:TreasurySharesMember2023-06-300001121404ifrs-full:RetainedEarningsMember2023-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-06-300001121404ifrs-full:NoncontrollingInterestsMember2023-06-3000011214042023-06-300001121404ifrs-full:RetainedEarningsMember2023-07-012023-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-07-012023-12-310001121404ifrs-full:NoncontrollingInterestsMember2023-07-012023-12-3100011214042023-07-012023-12-310001121404ifrs-full:TreasurySharesMember2023-07-012023-12-310001121404ifrs-full:IssuedCapitalMember2023-07-012023-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2023-07-012023-12-310001121404ifrs-full:IssuedCapitalMember2023-01-072023-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2023-01-072023-12-310001121404ifrs-full:TreasurySharesMember2023-01-072023-12-310001121404ifrs-full:RetainedEarningsMember2023-01-072023-12-3100011214042019-07-012019-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-07-012023-12-310001121404ifrs-full:IssuedCapitalMember2023-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2023-12-310001121404ifrs-full:TreasurySharesMember2023-12-310001121404ifrs-full:RetainedEarningsMember2023-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-12-310001121404ifrs-full:NoncontrollingInterestsMember2023-12-310001121404ifrs-full:RetainedEarningsMember2024-01-012024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2024-01-012024-06-300001121404ifrs-full:NoncontrollingInterestsMember2024-01-012024-06-300001121404ifrs-full:TreasurySharesMember2024-01-012024-06-300001121404ifrs-full:IssuedCapitalMember2024-01-012024-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2024-01-012024-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2024-01-012024-06-300001121404ifrs-full:IssuedCapitalMember2024-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2024-06-300001121404ifrs-full:TreasurySharesMember2024-06-300001121404ifrs-full:RetainedEarningsMember2024-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2024-06-300001121404ifrs-full:NoncontrollingInterestsMember2024-06-300001121404sny:CommercialPaperProgramInUSAMember2024-01-012024-06-300001121404sny:CommercialPaperProgramInUSAMember2023-01-012023-06-300001121404sny:CommercialPaperProgramInUSAMember2023-01-012023-12-310001121404country:AR2024-06-300001121404country:TR2024-06-300001121404sny:AssetsAcquisitionMember2024-05-300001121404sny:AssetsAcquisitionMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMember2023-01-012023-12-310001121404sny:BiopharmaSegmentMembersny:ManufacturingAndSupplyMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:ManufacturingAndSupplyMember2023-01-012023-12-310001121404sny:OpellaMember2024-01-012024-06-300001121404sny:OpellaMember2023-01-012023-12-310001121404sny:ConsumerHealthcareSegmentMembersny:ManufacturingAndSupplyMember2024-01-012024-06-300001121404sny:ConsumerHealthcareSegmentMembersny:ManufacturingAndSupplyMember2023-01-012023-12-310001121404ifrs-full:GrossCarryingAmountMembersny:AcquiredResearchAndDevelopmentMember2023-12-310001121404ifrs-full:GrossCarryingAmountMembersny:ProductsTrademarksAndOtherRightsMember2023-12-310001121404ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-12-310001121404ifrs-full:GrossCarryingAmountMember2023-12-310001121404ifrs-full:GrossCarryingAmountMembersny:AcquiredResearchAndDevelopmentMember2024-01-012024-06-300001121404ifrs-full:GrossCarryingAmountMembersny:ProductsTrademarksAndOtherRightsMember2024-01-012024-06-300001121404ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2024-01-012024-06-300001121404ifrs-full:GrossCarryingAmountMember2024-01-012024-06-300001121404ifrs-full:GrossCarryingAmountMembersny:AcquiredResearchAndDevelopmentMember2024-06-300001121404ifrs-full:GrossCarryingAmountMembersny:ProductsTrademarksAndOtherRightsMember2024-06-300001121404ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2024-06-300001121404ifrs-full:GrossCarryingAmountMember2024-06-300001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-12-310001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-12-310001121404ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-12-310001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-12-310001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-01-012024-06-300001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-01-012024-06-300001121404ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-01-012024-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-01-012024-06-300001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-06-300001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-06-300001121404ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-06-300001121404sny:AcquiredResearchAndDevelopmentMember2023-12-310001121404sny:ProductsTrademarksAndOtherRightsMember2023-12-310001121404ifrs-full:ComputerSoftwareMember2023-12-310001121404sny:OtherIntangibleAssetsExcludingSoftwareMember2024-01-012024-06-300001121404sny:NovavaxMembersny:VaccinesCoExclusiveLicensingAgreementMembersny:OtherIntangibleAssetsExcludingSoftwareMember2024-05-102024-05-100001121404sny:MarketedProductsMember2024-06-300001121404sny:MarketedProductsMember2023-12-310001121404sny:MarketedProductsMember2024-01-012024-06-300001121404sny:TechnologicalPlatformsMember2024-06-300001121404sny:TechnologicalPlatformsMember2023-12-310001121404sny:TechnologicalPlatformsMember2024-01-012024-06-300001121404ifrs-full:OtherIntangibleAssetsMember2024-01-012024-06-300001121404sny:EuroapiMember2024-01-012024-06-300001121404sny:EuroapiMember2024-06-300001121404sny:EuroapiMember2023-12-310001121404sny:InfraservGmbhAndCoHochstKGMember2024-01-012024-06-300001121404sny:InfraservGmbhAndCoHochstKGMember2024-06-300001121404sny:InfraservGmbhAndCoHochstKGMember2023-12-310001121404sny:MSPVaccineCompanyMember2024-01-012024-06-300001121404sny:MSPVaccineCompanyMember2024-06-300001121404sny:MSPVaccineCompanyMember2023-12-310001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2024-01-012024-06-300001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2024-06-300001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2023-12-310001121404sny:EuroapiMember2024-06-300001121404sny:EuroapiMember2023-12-310001121404sny:MCMVaccineBVMembersny:MSPVaccineCompanyMember2024-01-012024-06-300001121404sny:AssociatesAndJointVenturesMember2024-01-012024-06-300001121404sny:AssociatesAndJointVenturesMember2023-01-012023-06-300001121404sny:AssociatesAndJointVenturesMember2023-01-012023-12-310001121404sny:AssociatesAndJointVenturesMember2024-06-300001121404sny:AssociatesAndJointVenturesMember2023-06-300001121404sny:AssociatesAndJointVenturesMember2023-12-310001121404ifrs-full:TradingEquitySecuritiesMember2024-06-300001121404ifrs-full:TradingEquitySecuritiesMember2023-12-310001121404ifrs-full:DebtSecuritiesMember2024-06-300001121404ifrs-full:DebtSecuritiesMember2023-12-310001121404ifrs-full:AllowanceForCreditLossesMember2024-06-300001121404ifrs-full:AllowanceForCreditLossesMember2023-12-310001121404ifrs-full:NotLaterThanOneMonthMember2024-06-300001121404ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2024-06-300001121404ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2024-06-300001121404ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2024-06-300001121404ifrs-full:LaterThanOneYearMember2024-06-300001121404ifrs-full:NotLaterThanOneMonthMember2023-12-310001121404ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2023-12-310001121404ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2023-12-310001121404ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2023-12-310001121404ifrs-full:LaterThanOneYearMember2023-12-310001121404sny:SanofiMemberifrs-full:IssuedCapitalMember2024-01-012024-06-300001121404sny:ShareRepurchase2023ProgramMember2023-05-252023-05-250001121404sny:ShareRepurchase2023ProgramMember2024-01-012024-06-300001121404sny:ShareRepurchase2024ProgramMember2024-04-302024-04-300001121404sny:RestrictedSharePlan2024Member2024-01-012024-06-300001121404sny:WithoutMarketConditionMembersny:RestrictedSharePlan2024Member2024-01-012024-06-300001121404sny:RestrictedSharePlan2024Membersny:WithMarketConditionMember2024-01-012024-06-300001121404sny:ExcludingChiefExecutiveOfficerMembersny:RestrictedSharePlan2024Membersny:WithMarketConditionMember2024-01-012024-06-300001121404sny:ExcludingChiefExecutiveOfficerMembersny:RestrictedSharePlan2024AdditionalSharesMembersny:WithMarketConditionMember2024-01-012024-06-300001121404srt:ChiefExecutiveOfficerMembersny:RestrictedSharePlan2024Membersny:WithMarketConditionMember2024-01-012024-06-300001121404sny:RestrictedSharesMember2024-01-012024-06-300001121404sny:RestrictedSharesMember2023-01-012023-06-300001121404sny:RestrictedSharesMember2024-06-300001121404sny:RestrictedSharesMember2023-06-300001121404sny:RestrictedSharePlan2024Member2024-06-300001121404sny:RestrictedSharePlan2024Member2023-06-300001121404sny:RestrictedSharePlan2023Member2024-06-300001121404sny:RestrictedSharePlan2023Member2023-06-300001121404sny:RestrictedSharePlan2022Member2024-06-300001121404sny:RestrictedSharePlan2022Member2023-06-300001121404sny:RestrictedSharePlan2021Member2024-06-300001121404sny:RestrictedSharePlan2021Member2023-06-300001121404sny:RestrictedSharePlan2020Member2024-06-300001121404sny:RestrictedSharePlan2020Member2023-06-300001121404sny:EmployeeShareOwnershipPlanMember2024-01-310001121404sny:EmployeeShareOwnershipPlanMember2024-06-240001121404sny:EmployeeShareOwnershipPlanMember2024-01-012024-06-300001121404sny:EmployeeShareOwnershipPlanMember2023-02-020001121404sny:EmployeeShareOwnershipPlanMember2023-06-230001121404sny:EmployeeShareOwnershipPlanMember2023-01-012023-06-300001121404sny:StockOptionPlanMemberifrs-full:BottomOfRangeMembersny:ExercisePriceRangeTwoMember2024-06-300001121404sny:StockOptionPlanMemberifrs-full:TopOfRangeMembersny:ExercisePriceRangeTwoMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMember2024-01-012024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMemberifrs-full:BottomOfRangeMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMemberifrs-full:TopOfRangeMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMember2024-01-012024-06-300001121404sny:StockOptionPlanMemberifrs-full:BottomOfRangeMembersny:ExercisePriceRangeFourMember2024-06-300001121404sny:StockOptionPlanMemberifrs-full:TopOfRangeMembersny:ExercisePriceRangeFourMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMember2024-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMember2024-01-012024-06-300001121404sny:StockOptionPlanMember2024-06-300001121404sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001121404sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001121404sny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001121404sny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMembersny:DebtInstrumentsMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMembersny:DebtInstrumentsMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMembersny:DebtInstrumentsMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMembersny:ForeignCurrencyTranslationMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMembersny:ForeignCurrencyTranslationMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:AmortizedCostNettingMember2024-06-300001121404sny:AdjustmentToDebtMeasuredAtFairValueMember2024-06-300001121404sny:ValueOnRedemptionMember2024-06-300001121404sny:ValueOnRedemptionMember2023-12-310001121404sny:ValueOnRedemptionMembersny:NonCurrentLiabilitiesMember2024-06-300001121404sny:ValueOnRedemptionMembersny:CurrentLiabilitiesMember2024-06-300001121404sny:ValueOnRedemptionMembersny:NonCurrentLiabilitiesMember2023-12-310001121404sny:ValueOnRedemptionMembersny:CurrentLiabilitiesMember2023-12-310001121404sny:ValueOnRedemptionMembersny:NonCurrentAssetsMember2024-06-300001121404sny:CurrentAssetsMembersny:ValueOnRedemptionMember2024-06-300001121404sny:ValueOnRedemptionMembersny:NonCurrentAssetsMember2023-12-310001121404sny:CurrentAssetsMembersny:ValueOnRedemptionMember2023-12-310001121404sny:CommercialPaperProgramInUSAMembersny:ValueOnRedemptionMembersny:CurrentLiabilitiesMember2024-06-300001121404sny:ValueOnRedemptionMembersny:CommercialPaperProgramInFranceMembersny:CurrentLiabilitiesMember2024-06-300001121404sny:FixedRateBondMaturingApril2024Redeemed2024Membersny:SanofiEuroMediumTermNotesMember2024-06-300001121404sny:SyndicatedCreditFacilityOneMember2024-06-300001121404sny:CommercialPaperProgramInFranceMember2024-06-300001121404sny:CommercialPaperProgramInUSAMember2024-06-300001121404sny:CommercialPaperProgramInUSAMembersny:SanofiEuroMediumTermNotesMember2024-01-012024-06-300001121404sny:SanofiEuroMediumTermNotesMembersny:CommercialPaperProgramInFranceMember2024-01-012024-06-300001121404sny:AtMarketValueMember2024-06-300001121404sny:AtMarketValueMember2023-12-310001121404sny:ValueOnRedemptionMember2024-01-012024-06-300001121404sny:ValueOnRedemptionMember2023-01-012023-12-310001121404sny:ForwardCurrencySalesMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ForwardCurrencySalesMemberifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesMemberifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ForwardCurrencySalesMembersny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:ForwardCurrencySalesMembersny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesMembersny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2024-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMembersny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMembersny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMembersny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMembersny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInSingaporeDollarMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesMember2024-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInUSDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404sny:ForwardCurrencyPurchasesInRussianRoubleMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInRussianRoubleMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInRussianRoubleMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInRussianRoubleMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInRussianRoubleMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInRussianRoubleMembersny:AtNotionalAmountMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInRussianRoubleMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInTurkishLiraMember2024-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMembersny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2024-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMembersny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2024-06-300001121404sny:AtNotionalAmountMember2024-06-300001121404ifrs-full:AtFairValueMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2024-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404ifrs-full:AtFairValueMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInChineseYuanRenminbiMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInChineseYuanRenminbiMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInCanadianDollarMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInCanadianDollarMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404ifrs-full:AtFairValueMemberifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2024-06-300001121404sny:ForwardCurrencyPurchasesInHungarianFlorintMembersny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:ForwardCurrencyPurchasesInHungarianFlorintMemberifrs-full:AtFairValueMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:ForwardCurrencySalesInUSDollarMember2024-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarUSBondMember2024-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarUSBondMember2024-01-012024-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarCommercialPaperMember2024-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarCommercialPaperMember2024-01-012024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:AtFairValueMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2024-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Memberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Member2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2024-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Member2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Member2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Membersny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Membersny:AtNotionalAmountMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Memberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Membersny:AtNotionalAmountMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Membersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Memberifrs-full:AtFairValueMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Memberifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Memberifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2024-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive3.56Memberifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2024-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:InterestRateSwapsPayCapitalizedEsterReceive3.56Memberifrs-full:CashFlowHedgesMember2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:NotLaterThanOneYearMember2024-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:AtNotionalAmountMember2024-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:AtNotionalAmountMember2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-06-300001121404sny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2024-06-300001121404ifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2024-06-300001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2023-12-310001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2023-12-310001121404sny:ContingentConsiderationArisingFromAcquisitionOfAmunixMember2023-12-310001121404sny:OtherLiabilities1Member2023-12-310001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2024-01-012024-06-300001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2024-01-012024-06-300001121404sny:ContingentConsiderationArisingFromAcquisitionOfAmunixMember2024-01-012024-06-300001121404sny:OtherLiabilities1Member2024-01-012024-06-300001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2024-06-300001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2024-06-300001121404sny:ContingentConsiderationArisingFromAcquisitionOfAmunixMember2024-06-300001121404sny:OtherLiabilities1Member2024-06-300001121404sny:SwedishOrphanBiovitrumABMembersny:AntibodiesCollaborationAgreementMember2024-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembersny:SwedishOrphanBiovitrumABMembersny:AntibodiesCollaborationAgreementMember2024-06-300001121404sny:SwedishOrphanBiovitrumABMembersny:AntibodiesCollaborationAgreementMemberifrs-full:LaterThanFiveYearsMember2024-06-300001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2023-12-310001121404sny:ProvisionsForOtherLongTermBenefitsMember2023-12-310001121404sny:NonCurrentRestructuringProvisionMember2023-12-310001121404ifrs-full:MiscellaneousOtherProvisionsMember2023-12-310001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2024-01-012024-06-300001121404sny:ProvisionsForOtherLongTermBenefitsMember2024-01-012024-06-300001121404sny:NonCurrentRestructuringProvisionMember2024-01-012024-06-300001121404ifrs-full:MiscellaneousOtherProvisionsMember2024-01-012024-06-300001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2024-06-300001121404sny:ProvisionsForOtherLongTermBenefitsMember2024-06-300001121404sny:NonCurrentRestructuringProvisionMember2024-06-300001121404ifrs-full:MiscellaneousOtherProvisionsMember2024-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMemberifrs-full:PlanAssetsMember2024-01-012024-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMemberifrs-full:PlanAssetsMember2023-01-012023-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMemberifrs-full:PlanAssetsMember2023-01-012023-12-310001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2024-01-012024-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2023-01-012023-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2023-01-012023-12-310001121404srt:MinimumMemberifrs-full:ActuarialAssumptionOfDiscountRatesMember2024-06-300001121404srt:MaximumMemberifrs-full:ActuarialAssumptionOfDiscountRatesMember2024-06-300001121404sny:UKZONEMemberifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember2024-06-300001121404srt:MinimumMemberifrs-full:ActuarialAssumptionOfDiscountRatesMember2023-06-300001121404srt:MaximumMemberifrs-full:ActuarialAssumptionOfDiscountRatesMember2023-06-300001121404sny:EUROZONEMemberifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember2023-06-300001121404sny:NovavaxMember2024-05-102024-05-100001121404sny:FulcrumTherapeuticsMember2024-05-132024-05-130001121404sny:ActionForWhichWeAreDefendantMembersny:ProductLiabilitiesMembersny:TaxotereProductLitigationInTheUSMember2024-06-300001121404sny:ActionForWhichWeAreDefendantMembersny:ProductLiabilitiesMembersny:ZantacProductLitigationInTheUSMember2024-06-300001121404sny:ActionForWhichWeAreDefendantMembersny:ProductLiabilitiesMembersny:GoldBondProductLitigationInTheUSMember2024-06-300001121404sny:ActionForWhichWeAreDefendantMembersny:PlavixAttorneyGeneralActionInHawaiiMember2024-04-222024-05-210001121404ifrs-full:OtherRelatedPartiesMembersny:OtherOperatingIncomeExpenseMember2024-01-012024-06-300001121404ifrs-full:OtherRelatedPartiesMembersny:OtherOperatingIncomeExpenseMember2023-01-012023-06-300001121404sny:RegeneronMembersny:OtherOperatingIncomeExpenseMember2024-01-012024-06-300001121404sny:RegeneronMembersny:OtherOperatingIncomeExpenseMember2023-01-012023-06-300001121404sny:CommercializationRelatedExpensesMemberifrs-full:OtherRelatedPartiesMembersny:RegeneronMember2024-01-012024-06-300001121404sny:CommercializationRelatedExpensesMemberifrs-full:OtherRelatedPartiesMembersny:RegeneronMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember2024-01-012024-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember2023-01-012023-12-310001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember2024-01-012024-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember2023-01-012023-12-310001121404sny:AntibodiesAllianceMembersny:CommercializationRelatedExpensesMember2024-01-012024-06-300001121404sny:AntibodiesAllianceMembersny:CommercializationRelatedExpensesMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:CommercializationRelatedExpensesMember2023-01-012023-12-310001121404sny:AntibodiesAllianceMember2024-01-012024-06-300001121404sny:AntibodiesAllianceMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMember2023-01-012023-12-310001121404sny:OthersCounterpartyMember2024-01-012024-06-300001121404sny:OthersCounterpartyMember2023-01-012023-06-300001121404sny:OthersCounterpartyMember2023-01-012023-12-310001121404sny:RegeneronMembersny:OtherOperatingIncomeExpenseMember2023-01-012023-12-3100011214042022-07-012023-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2024-01-012024-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2023-01-012023-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2023-01-012023-12-310001121404sny:BiopharmaSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:PharmaSegmentMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:PharmaSegmentMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:PharmaSegmentMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:PharmaSegmentMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:PharmaSegmentMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:PharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:PharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:PharmaSegmentMember2023-01-012023-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:DupixentMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:DupixentMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:PharmaLaunchesMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:PharmaLaunchesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:PharmaLaunchesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:PharmaLaunchesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:PharmaLaunchesMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:PharmaLaunchesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:PharmaLaunchesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:PharmaLaunchesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:NexviazymeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:NexviazymeMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:NexviazymeMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:NexviazymeMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:NexviazymeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:NexviazymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:NexviazymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:NexviazymeMember2023-01-012023-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404sny:SarclisaMembercountry:USsny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404sny:SarclisaMembercountry:USsny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:AltuviiioMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:AltuviiioMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:RezurockMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:RezurockMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:CabliviMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:CabliviMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:CabliviMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:CabliviMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:CabliviMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:CabliviMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:CabliviMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:CabliviMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:XenpozymeMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:XenpozymeMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:XenpozymeMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:XenpozymeMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:XenpozymeMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:XenpozymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:XenpozymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:XenpozymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:EnjaymoMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:EnjaymoMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:EnjaymoMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:EnjaymoMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:EnjaymoMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:EnjaymoMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:EnjaymoMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:EnjaymoMember2023-01-012023-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:TzieldMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:TzieldMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:OtherProductsSegmentMembersny:OtherProductsSegmentMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:OtherProductsSegmentMembersny:OtherProductsSegmentMember2024-01-012024-06-300001121404sny:OtherProductsSegmentMembersny:OtherCountriesMembersny:OtherProductsSegmentMember2024-01-012024-06-300001121404sny:OtherProductsSegmentMembersny:OtherProductsSegmentMember2024-01-012024-06-300001121404sny:OtherProductsSegmentMembersny:OtherProductsSegmentMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:OtherProductsSegmentMembersny:OtherProductsSegmentMember2023-01-012023-06-300001121404sny:OtherProductsSegmentMembersny:OtherCountriesMembersny:OtherProductsSegmentMember2023-01-012023-06-300001121404sny:OtherProductsSegmentMembersny:OtherProductsSegmentMember2023-01-012023-06-300001121404sny:OtherProductsSegmentMembersny:IndustrialSalesMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:OtherProductsSegmentMembersny:IndustrialSalesMember2024-01-012024-06-300001121404sny:OtherProductsSegmentMembersny:IndustrialSalesMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:OtherProductsSegmentMembersny:IndustrialSalesMember2024-01-012024-06-300001121404sny:OtherProductsSegmentMembersny:IndustrialSalesMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:OtherProductsSegmentMembersny:IndustrialSalesMember2023-01-012023-06-300001121404sny:OtherProductsSegmentMembersny:IndustrialSalesMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:OtherProductsSegmentMembersny:IndustrialSalesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:VaccinesMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:VaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:VaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:VaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:VaccinesMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:VaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:VaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:VaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:InfluenzaVaccinesMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:InfluenzaVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:InfluenzaVaccinesMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:InfluenzaVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersrt:EuropeMembersny:PolioPertussisHibVaccinesMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:OtherCountriesMembersny:PolioPertussisHibVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:RSVVaccinesMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:RSVVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:RSVVaccinesMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:RSVVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:RSVVaccinesMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:RSVVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:RSVVaccinesMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:RSVVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMembersny:OtherCountriesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMembersny:OtherCountriesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2023-01-012023-06-300001121404sny:OpellaMembersrt:EuropeMember2024-01-012024-06-300001121404country:USsny:OpellaMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:OpellaMember2024-01-012024-06-300001121404sny:OpellaMembersrt:EuropeMember2023-01-012023-06-300001121404country:USsny:OpellaMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:OpellaMember2023-01-012023-06-300001121404sny:OpellaMember2023-01-012023-06-300001121404sny:SeasonalSymptomsAndPainReliefMembersny:OpellaMember2024-01-012024-06-300001121404sny:SeasonalSymptomsAndPainReliefMembersny:OpellaMember2023-01-012023-06-300001121404sny:OpellaMembersny:WellnessBrandsMember2024-01-012024-06-300001121404sny:OpellaMembersny:WellnessBrandsMember2023-01-012023-06-300001121404sny:OthersMembersny:OpellaMember2024-01-012024-06-300001121404sny:OthersMembersny:OpellaMember2023-01-012023-06-300001121404srt:EuropeMember2024-01-012024-06-300001121404country:US2024-01-012024-06-300001121404sny:OtherCountriesMember2024-01-012024-06-300001121404srt:EuropeMember2023-01-012023-06-300001121404country:US2023-01-012023-06-300001121404sny:OtherCountriesMember2023-01-012023-06-300001121404ifrs-full:AllOtherSegmentsMember2024-01-012024-06-300001121404ifrs-full:ReportableSegmentsMember2024-01-012024-06-300001121404ifrs-full:AllOtherSegmentsMember2023-01-012023-06-300001121404ifrs-full:ReportableSegmentsMember2023-01-012023-06-300001121404ifrs-full:AllOtherSegmentsMember2023-01-012023-12-310001121404ifrs-full:ReportableSegmentsMember2023-01-012023-12-310001121404ifrs-full:OperatingSegmentsMember2024-01-012024-06-300001121404ifrs-full:OperatingSegmentsMember2023-01-012023-06-300001121404ifrs-full:OperatingSegmentsMember2023-01-012023-12-310001121404ifrs-full:MaterialReconcilingItemsMember2024-01-012024-06-300001121404ifrs-full:MaterialReconcilingItemsMember2023-01-012023-06-300001121404ifrs-full:MaterialReconcilingItemsMember2023-01-012023-12-310001121404sny:BiopharmaSegmentMember2024-06-300001121404sny:OpellaMember2024-06-300001121404ifrs-full:ReportableSegmentsMember2024-06-300001121404sny:BiopharmaSegmentMember2023-06-300001121404sny:ConsumerHealthcareSegmentMember2023-06-300001121404ifrs-full:ReportableSegmentsMember2023-06-300001121404sny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMember2023-12-310001121404sny:OpellaMember2023-12-310001121404ifrs-full:ReportableSegmentsMember2023-12-310001121404sny:ReportableGeographicalZonesMember2024-01-012024-06-300001121404country:FR2024-01-012024-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2024-01-012024-06-300001121404sny:ReportableGeographicalZonesMember2024-06-300001121404srt:EuropeMember2024-06-300001121404country:FR2024-06-300001121404country:US2024-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2024-06-300001121404sny:ReportableGeographicalZonesMember2023-01-012023-06-300001121404country:FR2023-01-012023-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2023-01-012023-06-300001121404sny:ReportableGeographicalZonesMember2023-06-300001121404srt:EuropeMember2023-06-300001121404country:FR2023-06-300001121404country:US2023-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2023-06-300001121404sny:ReportableGeographicalZonesMember2023-01-012023-12-310001121404srt:EuropeMember2023-01-012023-12-310001121404country:FR2023-01-012023-12-310001121404country:US2023-01-012023-12-310001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2023-01-012023-12-310001121404sny:ReportableGeographicalZonesMember2023-12-310001121404srt:EuropeMember2023-12-310001121404country:FR2023-12-310001121404country:US2023-12-310001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2023-12-310001121404sny:CertainWholesalersInTheUnitedStatesMember2024-01-012024-06-300001121404sny:CustomerOneMember2024-01-012024-06-300001121404sny:CustomerTwoMember2024-01-012024-06-300001121404sny:CustomerThreeMember2024-01-012024-06-300001121404sny:CustomerOneMember2023-01-012023-06-300001121404sny:CustomerTwoMember2023-01-012023-06-300001121404sny:CustomerThreeMember2023-01-012023-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2024
Commission File Number: 001-31368
SANOFI
(Translation of registrant’s name into English)
46 avenue de la Grande Armée – 75017 Paris
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
In July 2024, Sanofi issued the financial statements and half year management report attached hereto as Exhibit 99.1 and 99.2 which are incorporated herein by reference.
2024 HALF-YEAR FINANCIAL REPORT
Table of Contents
| | | | | | | | | | | |
1. | | 2 |
| CONSOLIDATED BALANCE SHEETS – ASSETS | 2 |
| CONSOLIDATED BALANCE SHEETS — SHAREHOLDERS’ EQUITY AND LIABILITIES | 3 |
| CONSOLIDATED INCOME STATEMENTS | 4 |
| CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | 5 |
| CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY | 6 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS | 8 |
| NOTES TO THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2024 | 10 |
| | INTRODUCTION | 10 |
| | A/ Basis of preparation of the half-year financial statements and accounting policies | 10 |
| | B/ Significant information for the first half of 2024 | 14 |
| | C/ Events subsequent to June 30, 2024 | 35 |
2 | HALF-YEAR MANAGEMENT REPORT | 37 |
| | A/ Significant events of the first half of 2024 | 37 |
| | B/ Progress on implementation of the Corporate Social Responsibility strategy | 40 |
| | C/ Events subsequent to June 30, 2024 | 43 |
| | D/ Consolidated financial statements for the first half of 2024 | 44 |
| | E/ Risk factors and related party transactions | 57 |
| | F/ Outlook | 58 |
| | G/ Appendix – Research and Development Pipeline | 60 |
3 | STATUTORY AUDITORS’ REPORT | 63 |
4 | RESPONSIBILITY STATEMENT OF THE CERTIFYING OFFICER – HALF-YEAR FINANCIAL REPORT | 64 |
| | | | | | | | |
Exhibit No. | | Description |
| | |
Exhibit 99.1 | Condensed half-year consolidated financial statements for 2024 | |
Exhibit 99.2 | 2024 Half-year management report, Statutory Auditors’ Report and Responsibility Statement | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Dated: July 25, 2024 | | | | | | SANOFI |
| | | | | | |
| | | | By: | | /s/ Alexandra Roger |
| | | | Name: | | Alexandra Roger |
| | | | Title: | | Head of Securities Law and Capital Markets |